메뉴 건너뛰기




Volumn 44, Issue 1, 2012, Pages 55-59

Successful treatment of congenital cytomegalovirus infection with valganciclovir

Author keywords

[No Author keywords available]

Indexed keywords

VALGANCICLOVIR; VIRUS DNA;

EID: 84856147694     PISSN: 00290831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (10)
  • 1
    • 84856188202 scopus 로고    scopus 로고
    • Japanese source
  • 2
    • 84856148948 scopus 로고    scopus 로고
    • http://mhlw-grants.niph.go.jp/niph/search/NISR00.do
  • 3
    • 84856188205 scopus 로고    scopus 로고
    • Japanese source
  • 4
    • 0036781318 scopus 로고    scopus 로고
    • Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant
    • DOI 10.1128/CMR.15.4.680-715.2002
    • Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15:680-715. (Pubitemid 41184084)
    • (2002) Clinical Microbiology Reviews , vol.15 , Issue.4 , pp. 680-715
    • Revello, M.G.1    Gerna, G.2
  • 5
    • 59649086482 scopus 로고    scopus 로고
    • Neuropathogenesis of congenital cytomegalovirus infection: Disease mechanisms and prospects for intervention
    • Cheeran MC, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection : disease mechanisms and prospects for intervention. Clin Microbiol Rev 2009;22:99-126.
    • (2009) Clin Microbiol Rev , vol.22 , pp. 99-126
    • Cheeran, M.C.1    Lokensgard, J.R.2    Schleiss, M.R.3
  • 7
    • 40949161526 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease
    • Kimberlin DW, Acosta EP, Sanchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis 2008;197:863-45.
    • (2008) J Infect Dis , vol.197 , pp. 863-945
    • Kimberlin, D.W.1    Acosta, E.P.2    Sanchez, P.J.3
  • 8
    • 33745618989 scopus 로고    scopus 로고
    • Valganciclovir for treatment of congenital cytomegalovirus infection
    • DOI 10.1007/s00431-006-0109-0
    • Schulzke S, Buhrer C. Valganciclovir for treatment of congenital cytomegalovirus infection. Eur J Pediatr 2006;165:575-6. (Pubitemid 43989420)
    • (2006) European Journal of Pediatrics , vol.165 , Issue.8 , pp. 575-576
    • Schulzke, S.1    Buhrer, C.2
  • 9
    • 71349084862 scopus 로고    scopus 로고
    • Oral valganciclovir treat-ment in newborns with symptomatic congenital cytomegalovirus infection
    • Lombardi G, Garofoli F, Villani P, et al. Oral valganciclovir treat-ment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2009;28:1465-70.
    • (2009) Eur J Clin Microbiol Infect Dis , vol.28 , pp. 1465-1470
    • Lombardi, G.1    Garofoli, F.2    Villani, P.3
  • 10
    • 80052868342 scopus 로고    scopus 로고
    • Efficacy of pro-longed valganciclovir therapy for congenital cytomegalovirus infection
    • Kashiwagi Y, Kawashima H, Nakajima J, et al. Efficacy of pro-longed valganciclovir therapy for congenital cytomegalovirus infection. J Infect Chemother 2011;17:538-40.
    • (2011) J Infect Chemother , vol.17 , pp. 538-540
    • Kashiwagi, Y.1    Kawashima, H.2    Nakajima, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.